AAAAAA
Results: 1-25/114
Authors:
TOREN A
ILAN Y
OR R
KAPELUSHNIK J
NAGLER A
Citation: A. Toren et al., IMPAIRED LIVER-FUNCTION TESTS IN PATIENTS TREATED WITH ANTITHYMOCYTE GLOBULIN - IMPLICATION FOR LIVER-TRANSPLANTATION, Medical oncology, 14(3-4), 1997, pp. 125-129
Authors:
RUBENSTEIN M
MIROCHNIK Y
RAY V
GUINAN P
Citation: M. Rubenstein et al., LACK OF TOXICITY ASSOCIATED WITH THE SYSTEMIC ADMINISTRATION OF ANTISENSE OLIGONUCLEOTIDES FOR TREATMENT OF RATS BEARING LNCAP PROSTATE TUMORS, Medical oncology, 14(3-4), 1997, pp. 131-136
Authors:
SHARMA S
PATI HP
MOHANTY A
Citation: S. Sharma et al., IN-VITRO COLONY FORMATION FROM FETAL LIVER-CELLS AND THEIR INFUSIONS IN PATIENTS OF APLASTIC-ANEMIA, Medical oncology, 14(3-4), 1997, pp. 137-139
Authors:
HELLSTEN S
STEINECK G
Citation: S. Hellsten et G. Steineck, BLADDER-CANCER IN SWEDEN, Medical oncology, 14(3-4), 1997, pp. 141-143
Authors:
GUINAN P
DIDOMENICO D
BROWN J
SHAW M
SHARIFI R
RAY V
SHOTT S
RUBENSTEIN M
Citation: P. Guinan et al., THE EFFECT OF ANDROGEN DEPRIVATION ON MALIGNANT AND BENIGN PROSTATE TISSUE, Medical oncology, 14(3-4), 1997, pp. 145-152
Authors:
AVILES A
Citation: A. Aviles, THE ROLE OF INTERFERON AS MAINTENANCE THERAPY IN MALIGNANT-LYMPHOMA, Medical oncology, 14(3-4), 1997, pp. 153-157
Authors:
MALIK UR
DUTCHER JP
CALIENDO G
LASALA P
MITNICK R
WIERNIK PH
Citation: Ur. Malik et al., PHASE-II TRIAL OF MERBARONE IN PATIENTS WITH MALIGNANT BRAIN-TUMORS, Medical oncology, 14(3-4), 1997, pp. 159-162
Authors:
JAN N
VILLANI GM
TRAMBERT J
FEHMIAN C
SOOD B
WIERNIK PH
Citation: N. Jan et al., A NOVEL 2ND LINE CHEMOTHERAPY TREATMENT OF RECURRENT THYMOMA, Medical oncology, 14(3-4), 1997, pp. 163-168
Authors:
COLOVIC MD
JANKOVIC GM
ELEZOVIC I
VIDOVIC A
BILA JS
NOVAK A
BABIC D
Citation: Md. Colovic et al., EFFECT OF ALL-TRANS-RETINOIC ACID ALONE OR IN COMBINATION WITH CHEMOTHERAPY IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA, Medical oncology, 14(2), 1997, pp. 65-72
Authors:
HANSSON J
Citation: J. Hansson, SYSTEMIC THERAPY OF MALIGNANT-MELANOMA, Medical oncology, 14(2), 1997, pp. 73-81
Authors:
LEVITZKI A
Citation: A. Levitzki, TARGETING SIGNAL-TRANSDUCTION FOR DISEASE THERAPY, Medical oncology, 14(2), 1997, pp. 83-89
Authors:
DIERDORF R
KREUTER U
JONES TC
Citation: R. Dierdorf et al., USE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN THE TREATMENT OF PROLONGED HEMATOPOIETIC DYSFUNCTION AFTER CHEMOTHERAPY ALONE ORCHEMOTHERAPY PLUS BONE-MARROW TRANSPLANTATION, Medical oncology, 14(2), 1997, pp. 91-98
Authors:
SHARMA S
PATI HP
AHUJA RK
TAKKAR D
KOCHUPILLAI V
Citation: S. Sharma et al., HEMATOPOIETIC-CELL COMPOSITION OF HUMAN FETAL LIVER, SPLEEN AND THYMUS, Medical oncology, 14(2), 1997, pp. 99-101
Authors:
BROCK CS
BOWER M
Citation: Cs. Brock et M. Bower, CURRENT PERSPECTIVES IN GLIOMAS, Medical oncology, 14(2), 1997, pp. 103-120
Authors:
YALCIN S
ZENGIN N
TEKUZMAN G
KUCUKALI T
Citation: S. Yalcin et al., PRIMARY NEUROENDOCRINE TUMOR OF THE BREAST, Medical oncology, 14(2), 1997, pp. 121-123
Authors:
BROWN PD
Citation: Pd. Brown, MATRIX METALLOPROTEINASE INHIBITORS IN THE TREATMENT OF CANCER, Medical oncology, 14(1), 1997, pp. 1-10
Authors:
RINGDEN O
Citation: O. Ringden, BONE-MARROW TRANSPLANTATION USING UNRELATED DONORS FOR HEMATOLOGICAL MALIGNANCIES, Medical oncology, 14(1), 1997, pp. 11-22
Authors:
RUBENSTEIN M
CHOU P
MIROCHNIK Y
GUINAN P
Citation: M. Rubenstein et al., ENHANCED EXPRESSION OF BCL-2 FOLLOWING ANTISENSE OLIGONUCLEOTIDE MEDIATED GROWTH-FACTOR DEPRIVATION, Medical oncology, 14(1), 1997, pp. 23-29
Authors:
COLOVIC M
JANKOVIC G
LAZAREVIC V
NOVAK A
Citation: M. Colovic et al., ACUTE MEGAKARYOBLASTIC LEUKEMIA IN A PATIENT WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Medical oncology, 14(1), 1997, pp. 31-34
Authors:
VIREN MMT
OJALA AT
KATAJA VV
MATTILA JJ
KOIVISTO PA
NIKKANEN VTA
Citation: Mmt. Viren et al., FLOW CYTOMETRIC ANALYSIS OF TUMOR DNA PROFILE RELATED TO RESPONSE TO TREATMENT AND SURVIVAL IN SMALL-CELL LUNG-CANCER, Medical oncology, 14(1), 1997, pp. 35-38
Authors:
MOROZ C
CHETRIT A
KAHN M
MODAN B
Citation: C. Moroz et al., FBL BLOOD-TEST AS A PREDICTIVE MARKER OF BREAST-CANCER IN HIGH-RISK WOMEN, Medical oncology, 14(1), 1997, pp. 39-42
Authors:
NOVIK Y
OLEKSOWICZ L
WIERNIK PH
Citation: Y. Novik et al., THERAPEUTIC EFFECT OF CYCLOSPORINE-A IN THROMBOCYTOPENIA AFTER MYELOABLATIVE CHEMOTHERAPY IN ACUTE MYELOID-LEUKEMIA, Medical oncology, 14(1), 1997, pp. 43-46
Authors:
IBRAHIM EM
ALMULHIM FA
Citation: Em. Ibrahim et Fa. Almulhim, EFFECT OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ON CHEMOTHERAPY-INDUCED ORAL MUCOSITIS IN NON-NEUTROPENIC CANCER-PATIENTS, Medical oncology, 14(1), 1997, pp. 47-51
Authors:
PAIETTA E
Citation: E. Paietta, CLASSICAL MULTIDRUG-RESISTANCE IN ACUTE MYELOID-LEUKEMIA, Medical oncology, 14(1), 1997, pp. 53-60
Authors:
YALCIN S
GULLU I
DEMIROGLU H
TEKUZMAN G
Citation: S. Yalcin et al., ACUTE-LEUKEMIA DURING TAMOXIFEN THERAPY, Medical oncology, 14(1), 1997, pp. 61-62